GET THE APP

Combined phacoemulsification with express device: A procedure of | 52378
Journal of Clinical and Experimental Ophthalmology

Journal of Clinical and Experimental Ophthalmology
Open Access

ISSN: 2155-9570

Combined phacoemulsification with express device: A procedure of choice in advanced open angle glaucoma


5th International Conference on Clinical & Experimental Ophthalmology

August 04-06, 2015 Valencia, Spain

Baswati Prasanth

Scientific Tracks Abstracts: J Clin Exp Ophthalmol

Abstract :

Purpose: To determine the intraocular pressure control and visual outcomes; following combined phacoemulsification with express
device, in cases of advanced open angle glaucoma.
Design: Retrospective, interventional, consecutive, non-comparative case series.
Participants: Patients of advanced glaucoma and cataract not controlled on maximal medication.
Methods: Single eye, in 6 patients, with advanced open angle glaucoma, on maximum anti-glaucomatous medical therapy, underwent
combined two-site surgery; Phacoemulsification with implantation of acrylic IOL followed by filtrating surgery, Ex-PRESS miniature
glaucoma shunt implantation was performed using 0.02% MMC. The standard procedure was performed under peribulbar anaesthesia
without complications; implantation was well positioned, whole surgery was performed by the same surgeon, in the Department of
Ophthalmology, Ahalia Hospital Abu Dhabi. Post-operatively, we recommended combined antibiotic and steroid drops every four
hours in the first week followed by taper.
Main Outcome Measures: Evaluated parameters were visual acuity, intraocular pressure control, bleb morphology on 1st, 7th postoperative
day, 1, 3 and 6 months after surgery. Surgical success was defined as 5 mm Hg≤intraocular pressure≤18 mm Hg, with or
without medications, without further glaucoma surgery.
Results: In a case series of six patients, the mean pre-operative intraocular pressure was 30.66±3.59 mm Hg on 3.83±0.37 anti-glaucoma
eye drops. The mean day 1, day 7, day 30, 90 and 180 days IOP were 12.83±2.96, 12.67±2.49, 12.0±2.82, 11.0±2.51, 11.34±3.20 mmHg,
respectively. Five out of six had IOP<18 mmHg without medication and all had IOP<18 mmHg with anti-glaucoma medication. No
intra-operative or post-operative complications were noted.
Conclusion: The Express Device demonstrates good IOP control in cases of advanced glaucoma with fewer propensities to hypotony
or wipe out.

Biography :

Baswati Prasanth, Specialist in Ophthalmology, has completed her MS Ophthalmology from Armed Forces Medical College, Pune and Fellowship in Glaucoma and Anterior
segment from Dr Shroff’s Eye Hospital, New Delhi. She is the winner of A D Patwardhan Gold medal from University of Pune. She is the Director of Ophthalmology, Ahalia
Hospital, Abu Dhabi. She has published more than 15 papers in reputed journals and has been part of several clinical trials.

Top